查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768774

全球3D生物列印市场

3D Bioprinting
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球 3D 生物列印市场规模将达到 89 亿美元

全球3D生物列印市场规模预计在2024年为37亿美元，预计2030年将达到89亿美元，2024年至2030年的复合年增长率为15.7%。报告分析的细分市场之一－喷墨列印市场，预计复合年增长率为16.3%，到分析期结束时规模将达到37亿美元。磁浮市场在分析期间的复合年增长率预计为16.9%。

美国市场预计将达到10亿美元，中国市场复合年增长率将达到14.8%

美国3D生物列印市场规模预计在2024年达到10亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到13亿美元，在2024-2030年的分析期间内，复合年增长率为14.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为13.9%和13.0%。在欧洲，预计德国市场的复合年增长率为11.2%。

全球3D生物列印市场－主要趋势与驱动因素摘要

什么是3D生物列印？

3D生物列印是一项突破性的技术，它将3D列印原理与生物科学相结合，用于创建功能性组织和器官。该过程涉及逐层沉积生物墨水（一种由活细胞和生物相容性材料製成的物质），以构建模拟人体组织生物复杂性的结构。 3D生物列印的第一步是数位设计阶段，使用专用软体创建组织或器官的模型。此数位蓝图使印表机能够极为精确地放置生物墨水。生物墨水本身经过精心配製，可模拟人体细胞的自然环境，并促进其生长发育。列印后，建造的组织在受控环境中培养，有时由支架材料支撑，以使细胞成熟和组织化。 3D生物列印的潜在应用范围非常广泛，从皮肤移植物和软骨的生产到肝臟和肾臟等更复杂的器官。随着生物列印技术的发展，它有望克服传统组织工程和器官移植方法面临的许多限制。

3D生物列印将如何改变医学和医疗保健？

3D生物列印对医学和医疗保健的变革性影响已逐渐显现，该技术已在多个关键领域提供革命性的解决方案。其中最重要的应用之一是器官移植，生物打印有望解决长期存在的捐赠器官短缺问题。研究人员在列印功能性、患者特异性器官（例如肾臟、心臟和肺臟）方面取得了突破。由于印刷的器官由接受者自身的细胞製成，因此可以显着缩短等待时间并降低器官排斥风险。除了移植之外，3D生物列印还透过创建个人化组织植入（例如烧烫伤患者的皮肤和用于关节修復的软骨）来增强再生医学领域，从而加快康復并改善患者预后。该技术也对药物测试和开发产生了重大影响。传统上，製药公司依靠动物模型进行临床前试验，但这些模型并不总是能准确预测人体反应。生物列印人体组织为药物测试提供了更可靠的平台，有助于改进潜在治疗方法的筛检，并减少药物开发平臺中代价高昂的后期失败。随着科技的进步，创造功能齐全的器官和个人化治疗方法的潜力日益增强，并将深刻改变医疗保健模式。

3D 生物列印面临哪些挑战和伦理考量？

儘管3D生物列印应用前景广阔，但它仍面临着许多技术、伦理和监管挑战，必须妥善应对才能充分发挥其潜力。主要的技术障碍之一是列印能够在人体内存活并整合的功能性组织的复杂性。虽然皮肤和软骨等简单组织已成功生物列印，但肝臟和心臟等复杂器官的生物列印仍面临重大挑战。这些器官需要复杂的血管网络来确保所有部位的血液供应充足，而复製如此复杂的结构仍然是一项重大挑战。此外，开发能够精确复製人体组织各种机械和生物学特性的生物墨水仍是一个持续的研究领域。从伦理角度来看，列印人体组织的能力引发了许多担忧。製造功能齐全的人体器官的可能性可能会引发围绕人类克隆和人体组织商业化的争论。此外，人们也担心公平分配的问题，因为这项技术初期成本高昂，只有那些负担得起的人才能使用，这可能会进一步加剧医疗保健的不平等。在监管方面，监管机构尚未适应生物列印带来的独特挑战。与传统医疗设备和药品不同，生物列印的组织和器官介于生物製品和合成製品之间，这引发瞭如何在临床广泛应用之前确保其安全性和有效性的问题。应对这些挑战对于3D生物列印技术的广泛应用和伦理道德至关重要。

是什么推动了 3D 生物列印市场的成长？

3D生物列印市场的成长受到多种因素的推动，所有这些因素都凸显了多个行业对这项革命性技术日益增长的需求。技术进步在市场扩张中发挥关键作用。生物列印设备的创新，例如能够列印更复杂设计的高解析度印表机，以及能够更好地模拟人体组织的生物墨水配方的进步，不断突破着可能性的界限。这些改进为医疗应用创造了新的可能性，吸引了公共和私营部门的投资。製药公司也是成长的主要驱动力，因为他们正在利用生物列印来加速药物研发和测试流程。该技术提供了一种更可靠、更具成本效益的替代方案，取代了通常依赖动物试验且可能无法很好地应用于人体生物学的传统方法。此外，与老化相关的慢性疾病和病症（例如心臟病和肝功能衰竭）的增多，正在推动对再生医学解决方案的需求，而3D生物列印正在提供针对患者的个人化治疗，从而改善治疗效果。另一个关键因素是消费者对个人化医疗的偏好日益增长。随着患者和医疗保健提供者越来越要求根据其个人基因图谱量身定制治疗方案，生物列印技术有望根据每位患者的独特需求量身定制组织和器官。此外，政府资金的涌入以及与学术机构的合作正在推动该领域的研发，进一步加速生物列印技术的创新和商业化。这些趋势表明，3D生物列印有望成为未来医疗保健领域不可或缺的一部分，其应用范围涵盖从器官移植到药物开发等各个领域。

部分

技术（喷墨、磁浮、雷射、其他技术）、材料（生物细胞、水凝胶、细胞外基质、其他材料）、最终用户（研究机构、学术机构、生物製药公司、医院）

受访公司范例

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical KK
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D SL
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP21002

Global 3D Bioprinting Market to Reach US$8.9 Billion by 2030

The global market for 3D Bioprinting estimated at US$3.7 Billion in the year 2024, is expected to reach US$8.9 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Inkjet-based, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Magnetic Levitation segment is estimated at 16.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 14.8% CAGR

The 3D Bioprinting market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.9% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global 3D Bioprinting Market - Key Trends and Drivers Summarized

What Is 3D Bioprinting and How Does It Work?

3D bioprinting is a groundbreaking technology that combines the principles of 3D printing with biological sciences to create functional tissues and organs. The process involves the layer-by-layer deposition of bio-inks, which are substances composed of living cells and biocompatible materials, to build structures that replicate the biological complexity of human tissues. The first step in 3D bioprinting is the digital design phase, where a model of the tissue or organ is created using specialized software. This digital blueprint guides the printer in placing bio-inks with extreme precision. The bio-inks themselves are carefully formulated to mimic the natural environment of human cells, promoting their growth and development. After printing, the constructed tissue is cultivated in a controlled environment to allow for cellular maturation and organization, sometimes supported by scaffolding materials. The potential applications of 3D bioprinting are vast, ranging from the production of skin grafts and cartilage to more complex organs like the liver and kidneys. As bioprinting technology evolves, it promises to overcome many of the limitations faced by traditional tissue engineering and organ transplantation methods.

How Is 3D Bioprinting Transforming Medicine and Healthcare?

The transformative impact of 3D bioprinting on medicine and healthcare is already becoming evident, with the technology offering revolutionary solutions in several key areas. One of the most significant applications is in organ transplantation, where bioprinting holds the promise of solving the chronic shortage of donor organs. Researchers are making strides in printing functional, patient-specific organs, such as kidneys, hearts, and lungs, which could drastically reduce waiting times and lower the risk of organ rejection, as the printed organs can be made from the recipient’s own cells. Beyond transplantation, 3D bioprinting is enhancing the field of regenerative medicine by enabling the creation of personalized tissue implants, such as skin for burn victims or cartilage for joint repair, that can accelerate recovery and improve patient outcomes. This technology is also having a profound effect on drug testing and development. Traditionally, pharmaceutical companies have relied on animal models for preclinical testing, but these models do not always accurately predict human responses. Bioprinted human tissues offer a more reliable platform for drug testing, allowing for better screening of potential treatments and a reduction in costly late-stage failures in drug development pipelines. As the technology advances, the potential for creating fully functional organs and personalized medical treatments will continue to grow, reshaping the healthcare landscape.

What Are the Challenges and Ethical Considerations in 3D Bioprinting?

Despite its promising applications, 3D bioprinting faces several technical, ethical, and regulatory challenges that need to be addressed for it to reach its full potential. One of the primary technical hurdles is the complexity of printing functional tissues that can survive and integrate into the human body. While simpler tissues like skin or cartilage have been successfully bioprinted, more complex organs such as the liver or heart pose significant challenges. These organs require intricate vascular networks to ensure a sufficient blood supply to all areas, and replicating such complex structures remains a major challenge. Moreover, the development of bio-inks that can accurately replicate the diverse mechanical and biological properties of human tissues is an ongoing area of research. Ethically, the ability to print human tissues raises a host of concerns. The potential for creating fully functional human organs could lead to debates over human cloning or the commodification of human tissues. Additionally, there is concern about the equitable distribution of this technology, as it may initially be prohibitively expensive and accessible only to those with the financial means, further exacerbating healthcare inequalities. On the regulatory side, governing bodies are still adapting to the unique challenges posed by bioprinting. Unlike traditional medical devices or pharmaceuticals, bioprinted tissues and organs straddle the line between biological products and synthetic materials, raising questions about how to ensure their safety and efficacy before they can be widely used in clinical settings. Addressing these challenges will be crucial to the widespread adoption and ethical use of 3D bioprinting technology.

What Are the Drivers Behind the Growth of the 3D Bioprinting Market?

The growth in the 3D bioprinting market is driven by several factors, all of which highlight the increasing demand for this revolutionary technology across multiple industries. Technological advancements are playing a critical role in the expansion of the market. Innovations in bioprinting equipment, such as higher resolution printers capable of more intricate designs, and advancements in bio-ink formulations that better mimic human tissues, are continuously pushing the boundaries of what can be achieved. These improvements have opened new possibilities in medical applications, attracting investment from both the public and private sectors. Pharmaceutical companies are also major drivers of growth, using bioprinting to accelerate drug discovery and testing processes. The technology offers a more reliable and cost-effective alternative to traditional methods, which often rely on animal testing that may not translate well to human biology. Additionally, the rise in chronic diseases and conditions associated with aging populations, such as heart disease and liver failure, is driving demand for regenerative medicine solutions, where 3D bioprinting offers patient-specific treatments that can improve outcomes. Another significant factor is the growing consumer preference for personalized medicine. Patients and healthcare providers are increasingly seeking treatments that are tailored to individual genetic profiles, and bioprinting offers the possibility of creating tissues and organs customized to each patient’s unique needs. Finally, the influx of government funding and partnerships with academic institutions has spurred research and development in the field, further accelerating innovation and the commercialization of bioprinting technologies. These trends indicate that 3D bioprinting is poised to become an integral part of the future of healthcare, with wide-ranging applications from organ transplantation to drug development.

SCOPE OF STUDY:

The report analyzes the 3D Bioprinting market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Inkjet-based, Magnetic Levitation, Laser-based, Other Technology); Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials); End-Use (Research Organizations & Academic Institutes, Biopharmaceutical Companies, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D S.L.
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • 3D Bioprinting - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Tissue Engineering Expands Market Opportunity for 3D Bioprinting
    • Technological Advancements in Bioinks Propel Growth in 3D Bioprinting Applications
    • Increasing Use of 3D Bioprinting in Drug Development and Testing Spurs Market Growth
    • Advances in Stem Cell Research Strengthen the Business Case for 3D Bioprinting in Regenerative Medicine
    • Growing Focus on Organ Transplantation Solutions Accelerates Demand for 3D Bioprinting
    • Here's the Story: Expanding Research in Cancer Therapeutics Drives Innovation in 3D Bioprinting
    • Increasing Application of 3D Bioprinting in Cosmetic Testing and Tissue Models Generates New Opportunities
    • Expanding Use of 3D Bioprinting in the Development of Complex Tissue Structures Strengthens Market Demand
    • Advances in Automation and Robotics Drive Efficiency in 3D Bioprinting Systems
    • Increasing Adoption of 3D Bioprinting in Academic and Research Institutes Expands Market Reach
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Living Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Living Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracellular Matrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Extracellular Matrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Research Organizations & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Research Organizations & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World 3D Bioprinting Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Inkjet-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Inkjet-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Magnetic Levitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Magnetic Levitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Laser-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Laser-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • JAPAN
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • CHINA
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • EUROPE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • FRANCE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • GERMANY
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030

IV. COMPETITION